pomegranateThe company recently announced that it will stop selling its flagship in the U.S. starting later this weekApple Watch Series 9 and Apple Watch Ultra 2. The decision comes as a result of a longstanding relationship between Apple and medical technology company Masimo around the Apple Watch's blood oxygen sensor technologypatent disputeThe
The patent dispute between Apple and Masimo has reportedly been going on for several years. In a recent ruling by the International Patent Dispute Resolution Organization (ITC), Masimo prevailed. Apple subsequently took action to stop selling the affected Apple Watch models.
image source network
In response to the decision, Apple said it will no longer sell the Apple Watch Series 9 and Ultra 2 in the U.S. and will gradually reduce inventory in other countries. Meanwhile, Apple will continue to sell other Apple Watch models that are not affected.
The incident has significant implications for the patent dispute between Apple and Masimo. For Apple, halting sales of the affected Apple Watch models will have some impact on its business. However, for consumers, it may push Apple to accelerate the development of new technologies or solutions to avoid similar problems from happening again.
The patent dispute between Apple and Masimo is one of the common issues in the technology industry. This incident reminds us that the protection of patent rights and intellectual property rights is crucial to driving innovation and development. At the same time, it is wise for consumers to choose a company with reliable patent rights and intellectual property protection.
This article comes from users or anonymous contributions, does not represent the position of Mass Intelligence; all content (including images, videos, etc.) in this article are copyrighted by the original author. Please refer to this site for the relevant issues involvedstatement denying or limiting responsibilityPlease contact the operator of this website for any infringement of rights (Contact Us) We will handle this as stated. Link to this article: https://dzzn.com/en/2023/2224.html
